Navigation Links
Unexpected Link Between Cancer and Diabetes Revealed

BOSTON, Sept. 29, 2011 /PRNewswire-USNewswire/ -- A pathway activated in cancer plays an unexpected key role in metabolic diseases like type 2 diabetes, according to a study by researchers at Children's Hospital Boston. Evidence that the Lin28/let-7 pathway influences the cellular response to glucose provides a unifying theme to perplexing data that associates human genetic variation with diabetes risk.

The multi-institutional research team led by George Q. Daley, MD, PhD, director of Stem Cell Transplantation and a leader in the Stem Cell Research Program at Children's Hospital Boston – reported their findings in the September 30 issue of the journal Cell.

Let-7 is a microRNA, a small RNA that dampens the expression of a large set of genes related to cell growth and development. Previously, the Daley lab reported that Lin28, an RNA-binding protein found at high levels in the embryo, blocks let-7 production and is aberrantly expressed in about 15% of all cancers.

"The relationship between Lin28 and let-7 is ancient, found in organisms as diverse as worms, mice, and humans," said Daley, a professor of biological chemistry and molecular pharmacology at Harvard Medical School and a Howard Hughes Medical Institute investigator. "This suggested to us that the Lin28/let-7 pathway was profoundly important, but we didn't expect such exciting results."

In the current study, Daley and his team, led by Hao Zhu and Ng Shyh-Chang, set out to study cancer by developing a trio of mouse models with altered expression of Lin28 and let-7. What they discovered, instead, were profound effects on glucose metabolism. When fed a high-fat diet, normal mice develop obesity and diabetes, but mice engineered to express surplus Lin28 remained lean and processed glucose efficiently while mice engineered to express surplus let-7 became diabetic even on a normal diet.

"The results were startling," said Daley. "Previously we had considered these molecules only as regulators of cell growth and cancer. But in these mice we discovered remarkable effects on sugar processing and diabetes."

Molecular studies showed that Lin28 and let-7 exert their influence on glucose control at multiple points along the evolutionarily ancient insulin signaling pathway. Components of this pathway, which manages growth and glucose metabolism at the cellular level, are also tied to the survival of multiple kinds of cancer.

"Cancer cells have a metabolism that is very embryo-like," Daley noted, "so we speculate that tumors take advantage of the Lin28/let-7 pathway to turn back the clock, in metabolic terms. It's a avenue we'll to study further."

To link their findings in mice to human metabolism, the researchers examined data on genetic variation found in patients with type 2 diabetes together with co-author David Altshuler of Harvard Medical School, a world authority on the genetics of diabetes. They found that many diabetes-associated genes were known or predicted let-7 targets.

"It can be difficult to link genetic association data to actual biochemical pathways in the cell," Daley explained. "Let-7 has hundreds, maybe even thousands, of gene targets. The genetic data, coupled to the striking similarities between the way our mice and patients with diabetes handle glucose argues that regulation by Lin28/let-7 is a unifying feature of many genes associated with diabetes."

The study was supported by the Howard Hughes Medical Institute; the National Institute of Diabetes and Digestive and Kidney Diseases; the National Human Genome Research Institute; the National Institute of General Medical Sciences; the Singapore Agency for Science, Technology, and Research; the American Cancer Society; the American Diabetes Association; the Pew Charitable Trusts, and the Burroughs Wellcome Fund.

Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including nine members of the National Academy of Sciences, 11 members of the Institute of Medicine and nine members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 396 bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Children's, visit:

Bess Andrews
Children's Hospital Boston

SOURCE Children's Hospital Boston
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Help the Haitian Community and Prepare for an Unexpected Disaster
2. Unexpected Side Effect: Makes You Happier
3. Prostate Cancer Treatment: Match Between CyberKnife And Robotic Prostate Surgery And The Winner Is?
4. Pharmaceutical Marketing Strategy Balances Support Between New & Established Products in the Same Indication
5. New Data Explore Mechanistic Differences Between FORTEO® and Zoledronic Acid
6. Licensing Agreement for Pharmaceutical Disposal Technology Between Teikoku Pharma USA, Inc. and Verde Environmental Technologies Inc.
7. Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
8. TRIA Beauty Leading the Charge in Bridging Gap Between Science and Skin Health
9. Bayer Study Reveals Gaps in Perception of Veterinary Care Between Vets and Pet Owners
10. New Data Showed Minimal Potential for Drug Interaction Between Cholesterol Drug LIVALO® and a Common Antiretroviral Therapy
11. B. Braun Acquires Patent for Enhanced Wireless Communication Between Medical Devices and Hospital Information Management Systems
Post Your Comments:
(Date:11/27/2015)... ) ... "2016 Global Tumor Marker Testing Market: Supplier ... Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive ... offering. --> ) has ... Global Tumor Marker Testing Market: Supplier Shares ...
(Date:11/26/2015)... UTRECHT , Nederland, November 26, 2015 ... --> Een nieuwe aanpak combineert ... van gevorderde kanker. ... -->      (Photo: ... van het Leids Universitair Medisch Centrum (LUMC) ...
(Date:11/26/2015)... ) has ... Future Horizons and Growth Strategies in the ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> ) has announced the ... and Growth Strategies in the French Drugs ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... November 28, 2015 , ... Safe storage for contraceptive devices may ... one from Lakewood, New Jersey and the other from Bradley Beach, New Jersey, there ... save the expense of having to replace NuvaRings more often than necessary. As such, ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... American Dental Association meeting in Washington D.C. revolved around the fact that proper dental ... health. The talk stressed the link between periodontal disease (more commonly referred to as ...
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, ... to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. ... dispense prescription medications. In doing so, it could help to prevent potential overdose ...
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... Health-E-minds, an innovative online platform for mental health and wellness consultation, has collaborated ... This partnership will bridge the knowledge gap experienced by parents and bring advice ...
Breaking Medicine News(10 mins):